Jailendra Singh
Stock Analyst at Truist Securities
(0.85)
# 3,914
Out of 5,065 analysts
188
Total ratings
26%
Success rate
-24.88%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $23.76 | +30.47% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $4.14 | +141.55% | 8 | Nov 10, 2025 | |
| IQV IQVIA Holdings | Reiterates: Buy | $235 → $265 | $224.90 | +17.83% | 17 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $20.05 | +79.55% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $34.71 | +6.60% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $164.56 | +42.20% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $591.82 | -26.33% | 5 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $35.74 | +42.70% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $25.86 | +4.41% | 10 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $50.42 | +20.98% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $45.99 | +4.37% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $6.96 | +29.31% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.71 | +102.95% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $3.84 | +95.31% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $22.50 | +104.44% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $244.06 | -13.96% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $9.69 | +44.48% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.62 | +946.03% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.47 | +274.64% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $2.69 | +1,498.51% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.76 | +769.57% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.42 | +181.69% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $209.48 | -72.31% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $2.57 | +1,650.97% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $866.03 | -61.55% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.28 | +294.74% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $28.17 | - | 3 | Jan 15, 2021 |
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $23.76
Upside: +30.47%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $4.14
Upside: +141.55%
IQVIA Holdings
Oct 29, 2025
Reiterates: Buy
Price Target: $235 → $265
Current: $224.90
Upside: +17.83%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $20.05
Upside: +79.55%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $34.71
Upside: +6.60%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $164.56
Upside: +42.20%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $591.82
Upside: -26.33%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $35.74
Upside: +42.70%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $25.86
Upside: +4.41%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $50.42
Upside: +20.98%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $45.99
Upside: +4.37%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $6.96
Upside: +29.31%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.71
Upside: +102.95%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $3.84
Upside: +95.31%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $22.50
Upside: +104.44%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $244.06
Upside: -13.96%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $9.69
Upside: +44.48%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.62
Upside: +946.03%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.47
Upside: +274.64%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $2.69
Upside: +1,498.51%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.76
Upside: +769.57%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.42
Upside: +181.69%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $209.48
Upside: -72.31%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $2.57
Upside: +1,650.97%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $866.03
Upside: -61.55%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.28
Upside: +294.74%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $28.17
Upside: -